United States · 119th Congress
HRES 1285
Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
Bill record: Congress.gov API US-GOV-PD
Summary AI-generated
HRES 1285 expresses the sense of the House of Representatives that over 25 years of evidence and peer-reviewed studies proving mifepristone is safe and effective should be respected. The resolution further states that laws and policies governing access to medication abortion care should be equitable, transparent, and based on the best available peer-reviewed evidence-based science. The bill has been referred to the House Committee on Energy and Commerce.
Software-generated, grounded only in the bill's own fields (it does not invent outcomes, amounts, or dates). Provenance: Congress.gov API US-GOV-PD GovTally LLM enrichment (local oMLX)
Issue tags AI-classified
Classified by a local model from the bill's text; confidence shown. GovTally LLM enrichment (local oMLX)
Latest action
Referred to the House Committee on Energy and Commerce. May 14, 2026
Sponsors
- Diana DeGette Democratic lead
- Diana DeGette Democratic lead